Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Radiological Signs of Latent Tuberculosis on Chest Radiography: A Systematic Review and Meta-Analysis.

Uzorka JW, Wallinga J, Kroft LJM, Ottenhoff THM, Arend SM.

Open Forum Infect Dis. 2019 Jul 1;6(7). pii: ofz313. doi: 10.1093/ofid/ofz313.

2.

To bridge, blossom or boost: that is the question.

Arend SM, Jedema I.

Clin Infect Dis. 2019 May 8. pii: ciz370. doi: 10.1093/cid/ciz370. [Epub ahead of print] No abstract available.

PMID:
31067571
3.

New developments on interferon-γ release assays for tuberculosis diagnosis.

Arend SM, Uzorka JW.

Lancet Infect Dis. 2019 Feb;19(2):121-122. doi: 10.1016/S1473-3099(18)30651-0. Epub 2019 Jan 14. No abstract available.

PMID:
30655048
4.

A recurrent migratory swelling.

Roach REJ, van Doorn R, de Bruïne FT, Arend SM, Visser LG.

Lancet Infect Dis. 2018 Sep;18(9):1045. doi: 10.1016/S1473-3099(18)30128-2. No abstract available.

PMID:
30152346
5.

Tuberculosis after a borderline QuantiFERON result during screening before infliximab.

Uzorka JW, Delfos NM, Witte AMC, Scheper H, van Soolingen D, Arend SM.

Eur Respir J. 2018 Aug 2;52(2). pii: 1800913. doi: 10.1183/13993003.00913-2018. Print 2018 Aug. No abstract available.

PMID:
30072541
6.

Borderline QuantiFERON results and the distinction between specific responses and test variability.

Uzorka JW, Bossink AWJ, Franken WPJ, Thijsen SFT, Leyten EMS, van Haeften AC, Doornenbal G, Boonstra P, Ottenhoff THM, Arend SM.

Tuberculosis (Edinb). 2018 Jul;111:102-108. doi: 10.1016/j.tube.2018.06.002. Epub 2018 Jun 7.

7.

Rifampin levels in daily practice: the accuracy of a single measurement.

Vanbrabant TJF, Dijkmans AC, den Hartigh J, Touw DJ, Arend SM.

Neth J Med. 2018 Jul;76(5):235-242.

8.

Diagnostic imaging of hepatic tuberculosis: case series.

Schininà V, Albarello F, Cristofaro M, Di Stefano F, Fusco N, Cuzzi G, Arend SM, Goletti D, Busi Rizzi E.

Int J Tuberc Lung Dis. 2018 Jul 1;22(7):779-787. doi: 10.5588/ijtld.17.0710.

PMID:
29914604
9.

A novel view on the pathogenesis of complications after intravesical BCG for bladder cancer.

Bilsen MP, van Meijgaarden KE, de Jong HK, Joosten SA, Prins C, Kroft LJM, Jonker JT, Crobach S, Pelger RC, Ottenhoff THM, Arend SM.

Int J Infect Dis. 2018 Jul;72:63-68. doi: 10.1016/j.ijid.2018.05.006. Epub 2018 May 17.

10.

Mycobacterial growth inhibition is associated with trained innate immunity.

Joosten SA, van Meijgaarden KE, Arend SM, Prins C, Oftung F, Korsvold GE, Kik SV, Arts RJ, van Crevel R, Netea MG, Ottenhoff TH.

J Clin Invest. 2018 May 1;128(5):1837-1851. doi: 10.1172/JCI97508. Epub 2018 Apr 3.

11.

Donor-derived tuberculosis via orthotopic liver transplantation.

Ruijter BN, van Wijngaarden AKS, van Hoek B, Mensen M, van Soolingen D, Arend SM.

Neth J Med. 2017 Nov;75(9):415-417.

12.

Performance of Xpert MTB/RIF Ultra: a matter of dead or alive.

Arend SM, van Soolingen D.

Lancet Infect Dis. 2018 Jan;18(1):8-10. doi: 10.1016/S1473-3099(17)30695-3. Epub 2017 Dec 5. No abstract available.

13.

Prediction and prevention of tuberculosis in contacts.

Arend SM, Uzorka JW.

Lancet Infect Dis. 2017 Dec;17(12):1237. doi: 10.1016/S1473-3099(17)30640-0. No abstract available.

PMID:
29173881
14.

Proof of concept that most borderline Quantiferon results are true antigen-specific responses.

Uzorka JW, Kroft LJM, Bakker JA, van Zwet EW, Huisman E, Knetsch-Prins C, van der Zwan CJ, Ottenhoff THM, Arend SM.

Eur Respir J. 2017 Nov 16;50(5). pii: 1701630. doi: 10.1183/13993003.01630-2017. Print 2017 Nov. No abstract available.

15.

Tenosynovitis caused by Mycobacterium malmoense in two kidney transplant recipients and review of the literature.

van Grootveld R, Scherer HU, Peters EEM, Gaasbeek A, Arend SM, Wunderink HF.

Transpl Infect Dis. 2018 Feb;20(1). doi: 10.1111/tid.12810. Epub 2017 Dec 21. Review.

PMID:
29125666
16.

Immunological characterization of latent tuberculosis infection in a low endemic country.

de Paus RA, van Meijgaarden KE, Prins C, Kamphorst MH, Arend SM, Ottenhoff THM, Joosten SA.

Tuberculosis (Edinb). 2017 Sep;106:62-72. doi: 10.1016/j.tube.2017.07.001. Epub 2017 Jul 4.

PMID:
28802407
17.

A critical assessment of the association between postnatal toxoplasmosis and epilepsy in immune-competent patients.

Uzorka JW, Arend SM.

Eur J Clin Microbiol Infect Dis. 2017 Jul;36(7):1111-1117. doi: 10.1007/s10096-016-2897-0. Epub 2017 Jan 12.

18.

General practitioner reported incidence of Lyme carditis in the Netherlands.

Hofhuis A, Arend SM, Davids CJ, Tukkie R, van Pelt W.

Neth Heart J. 2015 Nov;23(11):533-8. doi: 10.1007/s12471-015-0744-z.

19.

Editorial commentary: genotyping of Mycobacterium tuberculosis in China and missing links in the chain of ongoing transmission of tuberculosis.

Arend SM, van Soolingen D.

Clin Infect Dis. 2015 Jul 15;61(2):228-32. doi: 10.1093/cid/civ259. Epub 2015 Mar 31. No abstract available.

PMID:
25829002
20.

Ruxolitinib can mask symptoms and signs of necrotizing fasciitis.

Landman GW, Arend SM, van Dissel JT.

J Infect. 2013 Mar;66(3):296-7. doi: 10.1016/j.jinf.2012.11.011. Epub 2012 Nov 29. No abstract available.

PMID:
23201967
21.

Grading of a positive sputum smear and the risk of Mycobacterium tuberculosis transmission.

Lohmann EM, Koster BF, le Cessie S, Kamst-van Agterveld MP, van Soolingen D, Arend SM.

Int J Tuberc Lung Dis. 2012 Nov;16(11):1477-84. doi: 10.5588/ijtld.12.0129. Epub 2012 Sep 7.

PMID:
22964038
22.

[Helicobacter pylori-induced thrombocytopenia].

Samson AD, Arend SM, Zwaginga JJ, Schipperus M.

Ned Tijdschr Geneeskd. 2012;156(29):A4799. Review. Dutch.

PMID:
22831494
23.

Role of the QuantiFERON(R)-TB Gold In-Tube assay in screening new immigrants for tuberculosis infection.

Mulder C, van Deutekom H, Huisman EM, Toumanian S, Koster BF, Meijer-Veldman W, van Loenhout-Rooyackers JH, Appel M, Arend SM, Borgdorff MW, van Leth F.

Eur Respir J. 2012 Dec;40(6):1443-9. doi: 10.1183/09031936.00010612. Epub 2012 Apr 10.

24.

The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement.

Bumbacea D, Arend SM, Eyuboglu F, Fishman JA, Goletti D, Ison MG, Jones CE, Kampmann B, Kotton CN, Lange C, Ljungman P, Milburn H, Morris MI, Muller E, Muñoz P, Nellore A, Rieder HL, Sester U, Theodoropoulos N, Wagner D, Sester M.

Eur Respir J. 2012 Oct;40(4):990-1013. Epub 2012 Apr 10. Review.

25.

Two immigrants with tuberculosis of the ear, nose, and throat region with skull base and cranial nerve involvement.

Richardus RA, Jansen JC, Steens SC, Arend SM.

Case Rep Med. 2011;2011:675807. doi: 10.1155/2011/675807. Epub 2011 Apr 7.

26.

Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection.

van Dissel JT, Soonawala D, Joosten SA, Prins C, Arend SM, Bang P, Tingskov PN, Lingnau K, Nouta J, Hoff ST, Rosenkrands I, Kromann I, Ottenhoff TH, Doherty TM, Andersen P.

Vaccine. 2011 Mar 3;29(11):2100-9. doi: 10.1016/j.vaccine.2010.12.135. Epub 2011 Jan 20.

PMID:
21256189
27.

Editor's choice: Editorial commentary: Low level INH-resistant BCG: a sheep in wolf's clothing?

Arend SM, van Soolingen D.

Clin Infect Dis. 2011 Jan 1;52(1):89-93. doi: 10.1093/cid/ciq016. No abstract available.

PMID:
21148525
28.

Kinetics of a tuberculosis-specific gamma interferon release assay in military personnel with a positive tuberculin skin test.

van Brummelen SE, Bauwens AM, Schlösser NJ, Arend SM.

Clin Vaccine Immunol. 2010 Jun;17(6):937-43. doi: 10.1128/CVI.00005-10. Epub 2010 Apr 7.

29.

Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers.

van Dissel JT, Arend SM, Prins C, Bang P, Tingskov PN, Lingnau K, Nouta J, Klein MR, Rosenkrands I, Ottenhoff TH, Kromann I, Doherty TM, Andersen P.

Vaccine. 2010 Apr 30;28(20):3571-81. doi: 10.1016/j.vaccine.2010.02.094. Epub 2010 Mar 11.

PMID:
20226890
30.

Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts.

Kik SV, Franken WP, Mensen M, Cobelens FG, Kamphorst M, Arend SM, Erkens C, Gebhard A, Borgdorff MW, Verver S.

Eur Respir J. 2010 Jun;35(6):1346-53. doi: 10.1183/09031936.00098509. Epub 2009 Oct 19.

31.

Cross-reactive immunity to Mycobacterium tuberculosis DosR regulon-encoded antigens in individuals infected with environmental, nontuberculous mycobacteria.

Lin MY, Reddy TB, Arend SM, Friggen AH, Franken KL, van Meijgaarden KE, Verduyn MJ, Schoolnik GK, Klein MR, Ottenhoff TH.

Infect Immun. 2009 Nov;77(11):5071-9. doi: 10.1128/IAI.00457-09. Epub 2009 Sep 8.

32.

Variation in T-SPOT.TB spot interpretation between independent observers from different laboratories.

Franken WP, Thijsen S, Wolterbeek R, Bouwman JJ, el Bannoudi H, Kik SV, van Dissel JT, Arend SM.

Clin Vaccine Immunol. 2009 Oct;16(10):1439-42. doi: 10.1128/CVI.00456-08. Epub 2009 Aug 26.

33.

Interferon-gamma release assays in immigrant contacts and effect of remote exposure to Mycobacterium tuberculosis.

Kik SV, Franken WP, Arend SM, Mensen M, Cobelens FG, Kamphorst M, van Dissel JT, Borgdorff MW, Verver S.

Int J Tuberc Lung Dis. 2009 Jul;13(7):820-8.

PMID:
19555530
34.

A rare complication of BCG vaccination.

Middelburg TA, Snels DG, van Praag MC, Rudolphus A, Arend SM, Verhard EM, Hegt VN, de Man P.

Int J Dermatol. 2009 May;48(5):546-8. doi: 10.1111/j.1365-4632.2009.03644.x. No abstract available.

PMID:
19416395
35.

LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement.

Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, Goletti D, Bossink A, Magdorf K, Hölscher C, Kampmann B, Arend SM, Detjen A, Bothamley G, Zellweger JP, Milburn H, Diel R, Ravn P, Cobelens F, Cardona PJ, Kan B, Solovic I, Duarte R, Cirillo DM; C. Lange; TBNET.

Eur Respir J. 2009 May;33(5):956-73. doi: 10.1183/09031936.00120908.

36.

Diagnosis and treatment of lung infection with nontuberculous mycobacteria.

Arend SM, van Soolingen D, Ottenhoff TH.

Curr Opin Pulm Med. 2009 May;15(3):201-8. doi: 10.1097/MCP.0b013e3283292679. Review.

PMID:
19305349
37.

Interferon-gamma release assays during follow-up of tuberculin skin test-positive contacts.

Franken WP, Arend SM, Thijsen SF, Bouwman JJ, Koster BF, van Dissel JT, Bossink AW.

Int J Tuberc Lung Dis. 2008 Nov;12(11):1286-94.

PMID:
18926039
38.

Double-blind randomized Phase I study comparing rdESAT-6 to tuberculin as skin test reagent in the diagnosis of tuberculosis infection.

Arend SM, Franken WP, Aggerbeck H, Prins C, van Dissel JT, Thierry-Carstensen B, Tingskov PN, Weldingh K, Andersen P.

Tuberculosis (Edinb). 2008 May;88(3):249-61. Epub 2007 Dec 26.

PMID:
18155963
39.

A patient with de novo tuberculosis during anti-tumor necrosis factor-alpha therapy illustrating diagnostic pitfalls and paradoxical response to treatment.

Arend SM, Leyten EM, Franken WP, Huisman EM, van Dissel JT.

Clin Infect Dis. 2007 Dec 1;45(11):1470-5. Epub 2007 Oct 25.

PMID:
17990230
40.

Assessment of cross-reactivity between Mycobacterium bovis and M. kansasii ESAT-6 and CFP-10 at the T-cell epitope level.

Vordermeier HM, Brown J, Cockle PJ, Franken WP, Drijfhout JW, Arend SM, Ottenhoff TH, Jahans K, Hewinson RG.

Clin Vaccine Immunol. 2007 Sep;14(9):1203-9. Epub 2007 Aug 1. Erratum in: Clin Vaccine Immunol. 2007 Nov;14(11):1536. Drijfhout, Jan Wouter [added].

41.

T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individuals.

Martinez V, Carcelain G, Badell E, Jouan M, Mauger I, Sellier P, Truffot C, Bricaire F, Arend SM, Ottenhoff T, Autran B, Gicquel B.

BMC Infect Dis. 2007 Jul 26;7:83.

42.

Follow-up study of tuberculosis-exposed supermarket customers with negative tuberculin skin test results in association with positive gamma interferon release assay results.

Franken WP, Koster BF, Bossink AW, Thijsen SF, Bouwman JJ, van Dissel JT, Arend SM.

Clin Vaccine Immunol. 2007 Sep;14(9):1239-41. Epub 2007 Jul 11.

43.

Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation.

Leyten EM, Arend SM, Prins C, Cobelens FG, Ottenhoff TH, van Dissel JT.

Clin Vaccine Immunol. 2007 Jul;14(7):880-5. Epub 2007 May 16.

44.

Comparison of Mantoux and QuantiFERON TB Gold tests for diagnosis of latent tuberculosis infection in Army personnel.

Franken WP, Timmermans JF, Prins C, Slootman EJ, Dreverman J, Bruins H, van Dissel JT, Arend SM.

Clin Vaccine Immunol. 2007 Apr;14(4):477-80. Epub 2007 Feb 14.

45.

Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-gamma assay.

Leyten EM, Prins C, Bossink AW, Thijsen S, Ottenhoff TH, van Dissel JT, Arend SM.

Eur Respir J. 2007 Jun;29(6):1212-6. Epub 2007 Jan 10.

46.

Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts.

Arend SM, Thijsen SF, Leyten EM, Bouwman JJ, Franken WP, Koster BF, Cobelens FG, van Houte AJ, Bossink AW.

Am J Respir Crit Care Med. 2007 Mar 15;175(6):618-27. Epub 2006 Dec 14.

PMID:
17170386
47.

Risk factors of acute hepatic failure during antituberculosis treatment: two cases and literature review.

Smink F, van Hoek B, Ringers J, van Altena R, Arend SM.

Neth J Med. 2006 Nov;64(10):377-84. Review.

48.

Prospective controlled study of the diagnostic value of skin biopsy in patients with presumed meningococcal disease.

Arend SM, Lavrijsen AP, Kuijken I, van der Plas RN, Kuijper EJ.

Eur J Clin Microbiol Infect Dis. 2006 Oct;25(10):643-9.

PMID:
16964510
49.

Is the tuberculin skin test an accurate method of detecting tuberculosis in patients with rheumatoid arthritis?

Huizinga TW, Arend SM.

Nat Clin Pract Rheumatol. 2006 Apr;2(4):188-9. No abstract available.

PMID:
16932683
50.

Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis.

Leyten EM, Lin MY, Franken KL, Friggen AH, Prins C, van Meijgaarden KE, Voskuil MI, Weldingh K, Andersen P, Schoolnik GK, Arend SM, Ottenhoff TH, Klein MR.

Microbes Infect. 2006 Jul;8(8):2052-60. Epub 2006 Jun 13.

PMID:
16931093

Supplemental Content

Loading ...
Support Center